Tesaro is an oncology-focused biopharmaceutical company with a focus on developing treatments for cancer. Upon successful development and regulatory approval of any of its product candidates, the company intends to pursue commercialization in key product markets, including North America, Europe, and China. Tesaro is currently focused on commercializing products directly in North America, and directly or in partnership with established companies in Europe and China. The company's strategy is to identify, acquire, and develop promising drug candidates, and to commercialize cancer therapeutics that are potentially safer and more effective than existing treatments.
Quote | TESARO Inc. (NASDAQ:TSRO)
Last: | $ |
---|---|
Change Percent: | 0.03% |
Open: | $74.95 |
Close: | $74.96 |
High: | $74.97 |
Low: | $74.94 |
Volume: | 1,191,003 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | TESARO Inc. (NASDAQ:TSRO)
ImmunoGen is a promising turnaround equity that is approaching its inflection point in growth. Mirvetuximab is poised to gain approval toward yearend. In H2 this year, ImmunoGen is set to release a flurry of catalysts. For further details see: ImmunoGen: An Inflection Po...
Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trading stock that is about to embark on another bullish cycle. Despite being a tradi...
Message Board Posts | TESARO Inc. (NASDAQ:TSRO)
Subject | By | Source | When |
---|---|---|---|
$ARCS EHVVF MJTV TSNP RVVTF all 10000% gainers soon | amitgupta | investorshub | 12/14/2020 6:44:00 PM |
What run? GSK agreed to buy for | PolishWarBear | investorshub | 12/04/2018 3:12:06 PM |
Nice, looks like run starting | surge1k | investorshub | 12/04/2018 6:47:18 AM |
Winning!!!!! | silkyballer | investorshub | 12/03/2018 11:26:37 PM |
DEC. 21, 75$ call is a good buy | Hot trader101 | investorshub | 12/03/2018 4:02:45 PM |